3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
85
Stomach Neoplasms
16
Esophageal Neoplasms
14
Neoplasms
10
Cholangiocarcinoma
10
Carcinoma, Non-Small-Cell Lung
10
Breast Neoplasms
9
Neoplasm Metastasis
8
Adenocarcinoma Of Esophagus
8
Esophageal Squamous Cell Carcinoma
7
Endometrial Neoplasms
7
Colorectal Neoplasms
7
Pancreatic Adenocarcinoma
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Gallbladder Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Adenocarcinoma
5
Squamous Cell Carcinoma of Head and Neck
4
Prostatic Neoplasms
4
Melanoma
4
Biliary Tract Neoplasms
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Liver Neoplasms
3
Gastric Adenocarcinoma
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Anus Neoplasms
3
Advanced Pancreatic Cancer
3
Interventions
durvalumab
2
Nivolumab
2
Gemcitabine
2
tremelimumab
1
regorafenib
1
nilotinib
1
neratinib
1
encorafenib
1
Valproic Acid
1
Taxes
1
Standard of Care
1
Radiomics
1
Practice Guidelines as Topic
1
Palliative Care
1
Oxaliplatin
1
Leucovorin
1
Hepatectomy
1
Folfox protocol
1
Fluorouracil
1
Clinical Trials, Phase II as Topic
1
Clinical Trials, Phase I as Topic
1
Clinical Trials as Topic
1
Cisplatin
1
Cetuximab
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease Progression
×
Taxes
×
Gastrointestinal
×
Clear all
NCT07049055
2026-02-27
Carolyn-USA
Engeneic Pty Limited
Phase 1/2
Recruiting
144 enrolled